ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00459823
Recruitment Status : Suspended
First Posted : April 13, 2007
Last Update Posted : March 24, 2009
Sponsor:
Information provided by:
Eisai Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : June 2009
  Study Completion Date : No date given